Evolution of two protein kinases may hold key to unlocking highly specific cancer drugs

This is the story of Abl and Src -- two nearly identical protein kinases whose evolution may hold the key to unlocking new, highly specific cancer drugs.



from The Medical News http://ift.tt/1Dz7u2G

No comments:

Post a Comment